← Research library

[Using regulatory peptide imunofan in type 2 diabetes mellitus patients with diabetic foot syndrome].

Randomized study in people · 2009

What was studied
69 people with type 2 diabetes and diabetic foot: 39 adjunctive Imunofan, 30 basic-care controls
Main finding
A randomized 69-person diabetic-foot comparison reported better clinical and immune outcomes with adjunctive Imunofan, but its abstract supplies no numerical treatment effect.

Reported findings and study design

A randomized 69-person diabetic-foot comparison reported better clinical and immune outcomes with adjunctive Imunofan, but its abstract supplies no numerical treatment effect.

Imunofan + basic therapy 39; basic therapy 30; type 2 diabetes with diabetic foot and retinal angiopathy.

Results · Primary-publication indexed abstract; no full-text table appraisal
MeasureResultComparison, timing and statistics
Clinical, laboratory and quality-of-life findingsReported improvement with adjunctive treatmentNo scores, response rates or confidence intervals in the indexed abstract
Randomized groups39 adjunctive; 30 basic therapy

Group sizes describe the design. They must not be presented as wound-healing rates or evidence of prevention of amputation.

Source for these results ↗ · Reviewed 2026-11-01

Study limitations and source details

Study limitations

  • The abstract provides no numerical treatment effect, concealment or blinding details; no claim of fewer amputations follows.
  • Full methods, reporting completeness and independent replication remain to be appraised.

Source details

Original journal report

Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.

Abstract reviewed

Sources checked

Citation

Randomized trialEnglish abstract

Tutel'ian AV, Iakubovskaia IA, Skrypnik NV, Levedev VV. [Using regulatory peptide imunofan in type 2 diabetes mellitus patients with diabetic foot syndrome]. Terapevticheskii arkhiv · PMID 20481041

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards